Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India flag India · Delayed Price · Currency is INR
108.00
+4.00 (3.85%)
At close: Nov 9, 2026

NSE:ARISTO Revenue

In the fiscal year ending March 31, 2026, Aristo Bio-Tech and Lifescience had annual revenue of 3.64B INR with 14.34% growth. Aristo Bio-Tech and Lifescience had revenue of 1.07B in the half year ending March 31, 2026, a decrease of -4.50%. That makes Aristo Bio-Tech and Lifescience the 29,716th largest company in the world by revenue and 2,064th in India.

Revenue
3.64B
Revenue Growth
+14.34%
P/S Ratio
0.20
Revenue / Employee
74.23M
Employees
49
Market Cap
735.24M

Revenue Chart

Revenue by Geography

  • India 3.52B 96.7%
  • Export 67.55M 1.9%
  • Unallocated 52.02M 1.4%
Fiscal year ended Mar 31, 2026 See the full NSE:ARISTO breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20263.64B456.25M14.34%
Mar 31, 20253.18B729.45M29.76%
Mar 31, 20242.45B272.92M12.53%
Mar 31, 20232.18B520.92M31.43%
Mar 31, 20221.66B-14.55M-0.87%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.